Wilding, John Fernando, Kevin Milne, Nicola Evans, Marc Ali, Amar Bain, Steve James, June Newland-Jones, Philip Patel, Dipesh Viljoen, Adie SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice <p></p><p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-018-0471-8">here<b>.</b></a> </p> <p><br></p> <p><b>Provide enhanced content for this article</b></p> <p><br></p> <p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <a href="http://www.medengine.com/Redeem/”mailto:adisrapidplus@springer.com”"><b>adisrapidplus@springer.com</b></a>.</p> <p><br></p> <p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.</p> <p><br></p> <p>Other enhanced features include, but are not limited to:</p> <p><br></p> <p>• Slide decks</p> <p>• Videos and animations</p> <p>• Audio abstracts</p> <p>• Audio slides</p><br><p></p> Clinical guidance;Glucose-lowering medicines;Oral glucose-lowering medicines;Prescribing tools;Risk/benefit;SGLT2 inhibitors;Therapy choice;Type 2 diabetes 2019-02-15
    https://adisjournals.figshare.com/articles/dataset/SGLT2_Inhibitors_in_Type_2_Diabetes_Management_Key_Evidence_and_Implications_for_Clinical_Practice/6621683
10.6084/m9.figshare.6621683.v2